nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aminoglycoside antibiotics in infectious diseases: An overview
|
Siegenthaler, Walter E. |
|
1986 |
80 |
6S2 |
p. 2-14 13 p. |
artikel |
2 |
Aminoglycoside resistance: a worldwide perspective
|
Young, Lowell S. |
|
1986 |
80 |
6S2 |
p. 15-21 7 p. |
artikel |
3 |
Aminoglycosides in gynecologic infections
|
Ledger, William J. |
|
1986 |
80 |
6S2 |
p. 216-221 6 p. |
artikel |
4 |
Aminoglycosides plus beta-lactams against gram-negative organisms: Evaluation of in vitro synergy and chemical interactions
|
Giamarellou, Helen |
|
1986 |
80 |
6S2 |
p. 126-137 12 p. |
artikel |
5 |
Antibiotics delivered by an implantable drug pump: A new application for treating osteomyelitis
|
Perry, Clayton R. |
|
1986 |
80 |
6S2 |
p. 222-227 6 p. |
artikel |
6 |
Antibiotics in the second half of the 1980s: Areas of future development and the effect of new agents on aminoglycoside use
|
Neu, Harold C. |
|
1986 |
80 |
6S2 |
p. 195-203 9 p. |
artikel |
7 |
Arninoglycoside toxicity in infants and children
|
McCracken Jr., George H. |
|
1986 |
80 |
6S2 |
p. 172-178 7 p. |
artikel |
8 |
Challenging conventional aminoglycoside dosing regimens: The value of experimental models
|
Kapusnik, Joan E. |
|
1986 |
80 |
6S2 |
p. 179-181 3 p. |
artikel |
9 |
Choice of drug and dosage regimen: Two important risk factors for aminoglycoside nephrotoxicity
|
De Broe, Marc E. |
|
1986 |
80 |
6S2 |
p. 115-118 4 p. |
artikel |
10 |
Coagulase-negative staphylococci as nosocomial pathogens in neonates: The role of host defense, artificial devices, and bacterial hydrophobicity
|
Fleer, Andre |
|
1986 |
80 |
6S2 |
p. 161-165 5 p. |
artikel |
11 |
Combination antibiotic therapy in pediatrics
|
Chadwick, Ellen Gould |
|
1986 |
80 |
6S2 |
p. 166-171 6 p. |
artikel |
12 |
Combination therapy and monotherapy in the treatment of severe infection in the immunocompromised host
|
Gaya, Harold |
|
1986 |
80 |
6S2 |
p. 149-155 7 p. |
artikel |
13 |
Combination therapy: a way to limit emergence of resistance?
|
Michea-Hamzehpour, Mehri |
|
1986 |
80 |
6S2 |
p. 138-142 5 p. |
artikel |
14 |
Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside
|
Dejace, Pierre |
|
1986 |
80 |
6S2 |
p. 29-38 10 p. |
artikel |
15 |
Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin
|
Lerner, Stephen A. |
|
1986 |
80 |
6S2 |
p. 98-104 7 p. |
artikel |
16 |
Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin
|
Ruiz-Palacios, Guillermo M. |
|
1986 |
80 |
6S2 |
p. 71-75 5 p. |
artikel |
17 |
Cost-effective aminoglycoside therapy in surgical patients
|
Gladen, Herbert E. |
|
1986 |
80 |
6S2 |
p. 228-233 6 p. |
artikel |
18 |
Experimental studies on nephrotoxicity of aminoglycosides at low doses: Mechanisms and perspectives
|
Tulkens, Paul M. |
|
1986 |
80 |
6S2 |
p. 105-114 10 p. |
artikel |
19 |
Future trends in aminoglycoside therapy
|
Levin, Stuart |
|
1986 |
80 |
6S2 |
p. 190-194 5 p. |
artikel |
20 |
Have the new beta-lactams rendered the aminoglycosides obsolete for the treatment of serious nosocomial infections?
|
Moellering Jr., Robert C. |
|
1986 |
80 |
6S2 |
p. 44-47 4 p. |
artikel |
21 |
Introduction
|
Moellering Jr., Robert C. |
|
1986 |
80 |
6S2 |
p. 1- 1 p. |
artikel |
22 |
In vitro evaluations of amikacin: an assessment of the currently used methods of disk diffusion and dilution susceptibility, antimicrobial synergy, and the measurement of amikacin concentrations
|
Jones, Ronald N. |
|
1986 |
80 |
6S2 |
p. 88-97 10 p. |
artikel |
23 |
In vitro models for the study of combination antibiotic therapy in neutropenic patients
|
Zinner, Stephen H. |
|
1986 |
80 |
6S2 |
p. 156-160 5 p. |
artikel |
24 |
Management of intra-abdominal sepsis
|
Nichols, Ronald Lee |
|
1986 |
80 |
6S2 |
p. 204-209 6 p. |
artikel |
25 |
Management of sepsis in the elderly
|
Holloway, William J. |
|
1986 |
80 |
6S2 |
p. 143-148 6 p. |
artikel |
26 |
Prevalence and mechanisms of aminoglycoside resistance: A ten-year study
|
Phillips, Ian |
|
1986 |
80 |
6S2 |
p. 48-55 8 p. |
artikel |
27 |
Publisher's note
|
|
|
1986 |
80 |
6S2 |
p. ii- 1 p. |
artikel |
28 |
Qualitative overview of randomized trials of aminoglycosides
|
Evans, Denis A. |
|
1986 |
80 |
6S2 |
p. 39-43 5 p. |
artikel |
29 |
Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985
|
Gerding, Dale N. |
|
1986 |
80 |
6S2 |
p. 22-28 7 p. |
artikel |
30 |
Review of epidemic aminoglycoside resistance worldwide
|
Mayer, Kenneth H. |
|
1986 |
80 |
6S2 |
p. 56-64 9 p. |
artikel |
31 |
Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides
|
Meyer, Richard D. |
|
1986 |
80 |
6S2 |
p. 119-125 7 p. |
artikel |
32 |
Strategies in aminoglycoside use and impact upon resistance
|
Acar, Jacques F. |
|
1986 |
80 |
6S2 |
p. 82-87 6 p. |
artikel |
33 |
Surveillance of aminoglycoside resistance: European data
|
Van Landuyt, Herman W. |
|
1986 |
80 |
6S2 |
p. 76-81 6 p. |
artikel |
34 |
Susceptibility of aerobic gram-negative bacilli to aminoglycosides: Effects of 45 months of amikacin as first-line aminoglycoside therapy
|
Saavedra, Sonia |
|
1986 |
80 |
6S2 |
p. 65-70 6 p. |
artikel |
35 |
The potential for discovery and development of improved aminoglycosides
|
Price, Kenneth E. |
|
1986 |
80 |
6S2 |
p. 182-189 8 p. |
artikel |
36 |
Upper and lower urinary tract infections: Amikacin's role in managing surgical complications
|
Childs, Stacy J. |
|
1986 |
80 |
6S2 |
p. 210-215 6 p. |
artikel |